Design Science Group, LLC

Design Science Group, LLC is a U. S. -based firm specializing in human factors testing, focusing on user-centered design for healthcare products to enhance usability and safety. Founded in 1991 and headquartered in Philadelphia, US, Design Science Group, LLC provides human factors research for the healthcare industry, developing methodologies that support the design of medical devices and systems.

The CEO, Katie Hansbro, has a background in healthcare consulting, although further details on her prior roles are not specified. The company has engaged in one deal, with its most recent transaction taking place on January 21, 2026. Design Science Group, LLC is a leader in human factors testing, focusing on the user-centered design of healthcare products. Their core offerings include comprehensive research services that guide the development of medical devices and systems by improving usability, safety, and aesthetic appeal.

Their expertise encompasses a range of methodologies, including eye tracking, labeling and packaging development, and usability testing. These services are aimed at diverse end users, including medical professionals and patients, to ensure that products such as automated peritoneal dialysis cyclers meet critical safety and usability standards. The company operates primarily in the North American and European markets, catering to clients in the pharmaceutical, medical device, and healthcare sectors globally. The revenue model for Design Science centers on providing tailored human factors research and consulting services to its clientele.

Transactions typically involve project-based fees for services rendered, with contracts often structured around specific studies or research initiatives. Clients may include large pharmaceutical firms and medical device manufacturers, establishing long-term partnerships for ongoing research support. Pricing arrangements vary based on the scope and complexity of the projects, ensuring that clients receive customized solutions to meet regulatory and design requirements. These arrangements facilitate a direct business-to-business relationship, enabling the firm to deliver its specialized knowledge and expertise effectively.

On January 21, 2026, Design Science Group, LLC was acquired by BlueRidge Life Sciences, a portfolio company of Renovus Capital. The acquisition will allow BlueRidge Life Sciences to enhance its business development initiatives. The firms are expected to explore new product designs and services to strengthen their market position within the healthcare sector.